Lantheus Holdings (LNTH) Long-Term Investments (2024 - 2026)
Lantheus Holdings (LNTH) posted quarterly Long-Term Investments of $58.3 million for Q1 2026, up 91.97% year-over-year from $30.4 million in Q1 2025, and up 5201.09% quarter-over-quarter from $1.1 million in Q4 2025.
Lantheus Holdings (LNTH) Long-Term Investments (2024 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Long-Term Investments for 3 consecutive years, with $58.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Long-Term Investments rose 91.97% year-over-year to $58.3 million; the TTM figure through Mar 2026 stood at $58.3 million (up 91.97% YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
- Long-Term Investments grew to $58.3 million in Q1 2026 per LNTH's latest filing, from $1.1 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $158.8 million in Q3 2024 and bottomed at $1.1 million in Q4 2025.
- Historically, Long-Term Investments has averaged $74.4 million across 3 years, with a median of $52.4 million in 2025.
- Annual changes were most pronounced in 2025 — Long-Term Investments slumped 78.14% — and 2026, when it surged 91.97%.
- Lantheus Holdings' Long-Term Investments stood at $158.8 million in 2024, then plunged by 99.31% to $1.1 million in 2025, then surged by 5201.09% to $58.3 million in 2026.
- Business Quant data shows LNTH's Long-Term Investments at $58.3 million in Q1 2026, $1.1 million in Q4 2025, and $46.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 60.00 Mn |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 118.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 118.98 Mn |
| Mar 31, 2026 | 58.31 Mn |
| Dec 31, 2025 | 1.10 Mn |
| Sep 30, 2025 | 46.47 Mn |
| Jun 30, 2025 | 45.07 Mn |
| Mar 31, 2025 | 30.38 Mn |
| Sep 30, 2024 | 158.79 Mn |
| Jun 30, 2024 | 116.42 Mn |
| Mar 31, 2024 | 138.96 Mn |